1. Home
  2. KPTI vs INTT Comparison

KPTI vs INTT Comparison

Compare KPTI & INTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Karyopharm Therapeutics Inc.

KPTI

Karyopharm Therapeutics Inc.

N/A

Current Price

$5.38

Market Cap

172.6M

Sector

Health Care

ML Signal

N/A

Logo inTest Corporation

INTT

inTest Corporation

N/A

Current Price

$15.05

Market Cap

175.3M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
KPTI
INTT
Founded
2008
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
172.6M
175.3M
IPO Year
2013
1997

Fundamental Metrics

Financial Performance
Metric
KPTI
INTT
Price
$5.38
$15.05
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
2
Target Price
$17.50
$13.50
AVG Volume (30 Days)
659.3K
145.8K
Earning Date
05-11-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$146,067,000.00
$66,801,000.00
Revenue This Year
N/A
$13.07
Revenue Next Year
$46.62
$6.52
P/E Ratio
N/A
N/A
Revenue Growth
0.57
66.06
52 Week Low
$3.51
$5.24
52 Week High
$10.99
$15.01

Technical Indicators

Market Signals
Indicator
KPTI
INTT
Relative Strength Index (RSI) 26.90 75.85
Support Level $3.95 $7.21
Resistance Level $6.96 N/A
Average True Range (ATR) 0.88 0.92
MACD -0.36 -0.02
Stochastic Oscillator 5.83 93.27

Price Performance

Historical Comparison
KPTI
INTT

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).

About INTT inTest Corporation

inTest Corp is a supplier of test and process technology solutions for use in manufacturing and testing across a wide range of markets, including Semi, Auto/EV, Defense/Aerospace, Industrial, Life Sciences, Safety/Security, and Other. The Company has three operating segments, which are also its reportable segments and reporting units: Electronic Test, which generates the majority of its revenue and includes semiconductor test equipment, flying probe, and in-circuit testers; Environmental Technologies, which includes thermal test, process, and storage products; and Process Technologies, which includes induction heating and video imaging products. The Company generates the maximum revenue from the U.S.

Share on Social Networks: